News
SGLT2 inhibitor use was associated with an increased risk for erythrocytosis but not thrombosis among patients with type 2 diabetes.
In a mouse model of acute ischemic stroke, researchers showed that inhibiting the aggregation of GAPDH, either genetically or ...
The Peptide Therapeutics Market value was US$ $$ billion in 2022. The Peptide Therapeutics Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback